This can include reduced appetite, which can lead to early weight loss and better blood sugar control
Tips for Avoiding Drug and Food Interactions The Role of a Healthcare Provider in Managing Interactions Healthcare providers are indispensable in navigating potential interactions
This does not mean you should ignore severe side effects
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
What are my weight-loss goals